Wesana Health Holdings Inc.
WSNAF
$0.0255
-$0.0145-36.25%
| Weiss Ratings | WSNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | WSNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | WSNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.86 | |||
| Price History | WSNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -49.00% | |||
| 30-Day Total Return | -57.50% | |||
| 60-Day Total Return | 844.44% | |||
| 90-Day Total Return | 672.73% | |||
| Year to Date Total Return | 70.00% | |||
| 1-Year Total Return | 200.00% | |||
| 2-Year Total Return | -31.08% | |||
| 3-Year Total Return | -96.77% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -83.00% | |||
| 52-Week Low % Change | 920.00% | |||
| Price | WSNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.15 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Nov 13, 2024 | |||
| 52-Week High Price (Date) | Feb 03, 2025 | |||
| Valuation | WSNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 248.96K | |||
| Enterprise Value | 444.34K | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.03 | |||
| Earnings Per Share Growth | -49.62% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -1.47 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.03 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -1.04 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | WSNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 35.04M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | WSNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 773-236-7972 | |||
| Address | 433 West Van Buren Street Chicago, IL 60607 | |||
| Website | www.wesanahealth.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | WSNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | WSNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -24.28% | |||
| Return on Equity | -- | |||
| Income Statement | WSNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -417.70K | |||
| Net Income (TTM) | -1.17M | |||
| Net Income Avl. to Common (TTM) | -1.17M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 96.98% | |||
| EPS Diluted (TTM) | -0.03 | |||
| EPS Diluted Growth (Q YOY) | -110.42% | |||
| Balance Sheet | WSNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 46.90K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 124.40K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -603.40K | |||
| Current Ratio (Q) | 0.113 | |||
| Book Value Per Share (Q) | -$0.02 | |||
| Total Assets (Q) | 494.40K | |||
| Total Current Liabilities (Q) | 1.10M | |||
| Total Debt (Q) | 250.00K | |||
| Total Liabilities (Q) | 1.10M | |||
| Total Common Equity (Q) | -603.40K | |||
| Cash Flow | WSNAF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 387.60K | |||
| Cash from Financing (TTM) | 0.00 | |||
| Net Change in Cash (TTM) | -34.40K | |||
| Levered Free Cash Flow (TTM) | 594.10K | |||
| Cash from Operations (TTM) | -420.50K | |||
